News
Says unit ID Pharma Co., Ltd. grants Elixirgen non-exclusive rights to use Sendai Virus Vector technology to make products with Elixirgen's genes for research purpose and rights to sell the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback